Douglas E. Williams, Director at ARRAY BIOPHARMA INC (ARRY), bought 2,500 shares at $6.16 ($15K) on 2008-03-06, disclosed to the SEC on 2008-03-06.
Open-market purchase of $15k ARRY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| OVID | BUY | 2018-08-16 | $32K | — | Filing → |
| BIIB | SELL | 2015-06-22 | $1.6M | — | Filing → |